Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $352.7M
Liabilities Breakdown FY2022
Total Liabilities: $26.5M
Asset Breakdown
Total Assets: $352.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $29.4M | 8.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.7M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $27.2M | 7.7% |
| Other Assets | $292.4M | 82.9% |
Liabilities Breakdown
Total Liabilities: $26.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 12.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $23.2M | 87.4% |